GlassScriptPhysician profile
Justin Alfonso
NPI 1336502277
$32,690.82
in general payments reported to CMS, 2019-2025
33 companies · $1,757 in 2025
The $1,757 reported for 2025 was more than what 75% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24K · 2021: $3,235 · 2022: $1,734 · 2023: $840 · 2024: $1,158 · 2025: $1,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,129 · Consulting Fee: $555 · Education: $71.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,129.15 |
| Consulting Fee | $555.00 |
| Education | $71.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $21,575.00 | 2020 | |
| Abbott Laboratories | $5,150.73 | 2020-2025 | Eterna, Proclaim |
| Medtronic, INC. | $1,536.11 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $1,432.12 | 2021-2025 | Na, Wavewriter Alpha Prime 16, Infinion 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $509.17 | 2023-2025 | Relistor |
| Amgen INC. | $354.53 | 2021-2022 | |
| Abbvie INC. | $333.86 | 2022-2025 | Qulipta, Ubrelvy, Botox |
| Relievant Medsystems, INC. | $277.02 | 2021-2022 | |
| Lundbeck LLC | $263.04 | 2022-2025 | Vyepti |
| Scilex Pharmaceuticals INC. | $180.00 | 2021-2024 | Ztlido |
| Nevro Corp. | $142.38 | 2021-2022 | |
| Painteq LLC | $137.92 | 2023 | Painteq |
| Medtronic Vascular, INC. | $118.75 | 2020 | |
| Radius Health, INC. | $103.06 | 2021-2022 | |
| Saluda Medical Americas, INC. | $79.17 | 2025 | Evoke |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $75.60 | 2025 | |
| Spr Therapeutics, INC | $54.16 | 2023-2025 | Sprint Pns System |
| Biohaven Pharmaceutical Holding Company LTD. | $50.89 | 2022 | |
| Curonix LLC | $35.71 | 2022-2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kowa Pharmaceuticals America, INC. | $32.18 | 2022 | |
| Vertos Medical, INC. | $28.58 | 2024 | Mild Device Kit |
| Depuy Synthes Sales INC. | $26.39 | 2023 | Monovisc, Orthovisc |
| Pfizer INC. | $25.71 | 2025 | |
| Redhill Biopharma INC. | $23.33 | 2022 | |
| Amneal Pharmaceuticals LLC | $21.82 | 2023 | Lyvispah |
| Galderma Laboratories, L.P. | $18.82 | 2025 | Dysport |
| Allergan, INC. | $16.54 | 2021 | |
| Hikma Pharmaceuticals USA | $15.94 | 2022 | |
| Lilly USA, LLC | $15.41 | 2021 | |
| Stryker Corporation | $15.00 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.96 | 2021 | |
| Ibsa Pharma INC. | $13.94 | 2024 | Licart, Tirosint |
| Horizon Therapeutics Plc | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Alfonso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.